Project Details
Description
A Phase 3, Radomized, Controlled, Multi-Center, Open-Label Study fo Compare Tivozanib (AV-51) to Sorafenib in subjects with Advanced Renal Cell Carcinoma
| Status | Finished |
|---|---|
| Effective start/end date | 10/12/09 → 10/31/13 |
Funding
- AVEO PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.